RHBC
GWPH

R.H. Bluestein & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

R.H. Bluestein & Co’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,150
Closed -$247K – 377
2019
Q3 		$247K Buy
2,150
+150
+8% +$22.8K 0.01% 279
2019
Q2 		$345K Buy
+2,000
New +$346K 0.02% 208

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

R.H. Bluestein & Co's GWPH Position: Q4 2019 in Review

R.H. Bluestein & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 2,150 shares — an estimated $247K sold.

R.H. Bluestein & Co first reported a position in GWPH in Q2 2019 and held it in 2 quarters. The position peaked at $345K in Q2 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

  • R.H. Bluestein & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • R.H. Bluestein & Co sold 2,150 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $247K.
  • R.H. Bluestein & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 2 quarters.
  • R.H. Bluestein & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $345K in Q2 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on R.H. Bluestein & Co's 13F filing for Q4 2019, filed 13 Feb 2020.